The Rise, Fall, and Resurgence of Electroconvulsive Therapy.
Journal
Journal of psychiatric practice
ISSN: 1538-1145
Titre abrégé: J Psychiatr Pract
Pays: United States
ID NLM: 100901141
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
entrez:
10
11
2022
pubmed:
11
11
2022
medline:
15
11
2022
Statut:
epublish
Résumé
Electroconvulsive therapy (ECT) is one of the most effective treatments for depression. However, significant stigma from the media and the antipsychiatry movement has biased the public toward ECT, leading to underutilization, particularly among those most in need. This report reviews some of the key historical events in the rise, fall, and resurgence of ECT and how modern ECT knowledge and practice are more refined, including an improved understanding of its mechanisms of action and optimal treatment parameters.
Identifiants
pubmed: 36355582
doi: 10.1097/PRA.0000000000000666
pii: 00131746-202211000-00002
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
440-444Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Payne NA, Prudic J. Electroconvulsive therapy: part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract. 2009;15:346–368.
Zincir S, Öztürk P, Bilgen AE, et al. Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression. Neuropsychiatr Dis Treat. 2016;12:1389–1396.
Asch SS. Depression and demonic possession: the analyst as an exorcist. Hillside J Clin Psychiatry. 1985;7:149–164.
Hick C. “Humor macht kein kranckheit” [“Humor does not make disease”]—Paracelsus’ scientific revolution. Dtsch Med Wochenschr. 2018;143:1820–1825.
Gazdag G, Ungvari GS. Electroconvulsive therapy: 80 years old and still going strong. World J Psychiatry. 2019;9:1–6.
Shorter E. Sakel versus Meduna: different strokes, different styles of scientific discovery. J ECT. 2009;25:12–14.
Fink M. Meduna and the origins of convulsive therapy. Am J Psychiatry. 1984;141:1034–1041.
Fink M. Induced seizures as psychiatric therapy: Ladislas Meduna’s contributions in modern neuroscience. J ECT. 2004;20:133–136.
Strecker HP. Convulsion therapy in schizophrenia [Die Konvulsionstherapie der Schizophrenie]. By Ladislaus von Meduna. Halle a/S.: Carl Marhold, 1937. Pp. 121. J Mental Sci. 1937;83:727–728. Available at: https://www.cambridge.org/core/journals/journal-of-mental-science/article/abs/convulsion-therapy-in-schizophrenia-die-konvulsionstherapie-der-schizophrenie-by-ladislaus-von-meduna-halle-as-carl-marhold-1937-pp-121-price-rm-400/32B7D90E7DBF4BE9A947E14D16F7C55D . Accessed August 29, 2022.
Gazdag G, Bitter I, Ungvari GS, et al. László Meduna’s pilot studies with camphor inductions of seizures: the first 11 patients. J ECT. 2009;25:3–11.
Cooper K, Fink M. The chemical induction of seizures in psychiatric therapy: were flurothyl (indoklon) and pentylenetetrazol (metrazol) abandoned prematurely? J Clin Psychopharmacol. 2014;34:602–607.
Faedda GL, Becker I, Baroni A, et al. The origins of electroconvulsive therapy: Prof. Bini’s first report on ECT. J Affect Disord. 2010;120:12–15.
Accornero F. An eyewitness account of the discovery of electroshock. Convuls Ther. 1988;4:40–49.
Pace E. Lothar Kalinowsky, a psychiatrist, 92; used electroshocks. The New York Times . June 30, 1992. Available at: https://www.nytimes.com/1992/06/30/us/lothar-kalinowsky-a-psychiatrist-92-used-electroshocks.html . Accessed September 13, 2018.
Kalinowsky L. Electric-convulsion therapy in schizophrenia. Lancet. 1939;234:1232–1233.
Fink M. Convulsive therapy: a review of the first 55 years. J Affect Disord. 2001;63:1–15.
Goldbloom D. The Past, Present and Future of Electroconvulsive Therapy (ECT). Toronto, ON, Canada: Centre for Addiction and Mental Health (CAMH); 2018. Available at: https://www.camh.ca/en/camh-news-and-stories/the-past-present-and-future-of-electroconvulsive-therapy . Accessed September 28, 2021.
Lee K, Jenkins KD, Sparkle T. A narrative overview of current anesthetic drugs in electroconvulsive therapy. Life (Basel). 2021:11 981.
López-Muñoz F, Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009;15:1563–1586.
Hanrahan C, New JP. Antidepressant medications: the FDA-approval process and the need for updates. Ment Health Clin. 2014;4:11–16. Available at: https://doi.org/10.9740/mhc.n186950 .
doi: 10.9740/mhc.n186950
Wikipedia. Anti-psychiatry. Wikipedia April 2022. Available at: https://en.wikipedia.org/wiki/Anti-psychiatry . Accessed August 29, 2022.
Fink M. Impact of the antipsychiatry movement on the revival of electroconvulsive therapy in the United States. Psychiatr Clin North Am. 1991;14:793–801.
Kim H-H. Electroconvulsive therapy: a historical and legal perspective. Am J Psychiatry Resid J. 2018;13:10–11. Available at: https://doi.org/10.1176/appi.ajp-rj.2018.130305 .
doi: 10.1176/appi.ajp-rj.2018.130305
Lebensohn ZM. The history of electroconvulsive therapy in the United States and its place in American psychiatry: a personal memoir. Compr Psychiatry. 1999;40:173–181.
Sadowsky J. Electroconvulsive therapy: a history of controversy, but also of help. Scientific American, The Conversation , January 13, 2017. Available at: https://www.scientificamerican.com/article/electroconvulsive-therapy-a-history-of-controversy-but-also-of-help . Accessed July 8, 2020.
McKee J, George S, Caballero J. Psychiatry in the cinema. Ment Health Clin. 2011;1:110–111. Available at: https://doi.org/10.9740/mhc.n86989 .
doi: 10.9740/mhc.n86989
Shah R, Basu D. Coercion in psychiatric care: global and Indian perspective. Indian J Psychiatry. 2010;52:203–206.
Sienaert P. Based on a true story? The portrayal of ECT in international movies and television programs. Brain Stimul. 2016;9:882–891.
McCall WV. Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol. 2001;4:315–324.
Jain R. Single-action versus dual-action antidepressants. Prim Care Companion J Clin Psychiatry. 2004;6(suppl 1):7–11.
Webster JG. Encyclopedia of Medical Devices and Instrumentation (Vol 3), 2nd ed. Hoboken, NJ: Wiley-Interscience; 2006:6.
Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012;6:369–388.
Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2014. (CADTH Rapid Response Reports). Available at: http://www.ncbi.nlm.nih.gov/books/NBK263408 . Accessed May 12, 2022.
Sackeim HA. Modern electroconvulsive therapy: vastly improved yet greatly underused. JAMA Psychiatry. 2017;74:779–780.
Slade EP, Jahn DR, Regenold WT, et al. Association of electroconvulsive therapy with psychiatric readmissions in US hospitals. JAMA Psychiatry. 2017;74:798–804.
Fink M, Taylor MA. Electroconvulsive therapy: evidence and challenges. JAMA. 2007;298:330–332.
Blease CR. Electroconvulsive therapy, the placebo effect and informed consent. J Med Ethics. 2013;39:166–170.
Bow A. Is electroconvulsive therapy any more effective than simulated electroconvulsive therapy in treatment-resistant depression? Psychiatr Danub. 2018;30(suppl 7):502–507.
McCall WV, Andrade C, Sienaert P. Searching for the mechanism(s) of ECT’s therapeutic effect. J ECT. 2014;30:87–89.
McDonald WM, Weiner RD, Fochtmann LJ, et al. The FDA and ECT. J ECT. 2016;32:75–77.
Abrams R. Electroconvulsive Therapy. New York, NY: Oxford University Press; 2002.
Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London). 2014;4:33–54.
Haq AU, Sitzmann AF, Goldman ML, et al. Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry. 2015;76:1374–1384.
Heijnen WT, Birkenhäger TK, Wierdsma AI, et al. Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol. 2010;30:616–619.
Kho KH, van Vreeswijk MF, Simpson S, et al. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT. 2003;19:139–147.
UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361:799–808.
Loo CK, Katalinic N, Martin D, et al. A review of ultrabrief pulse width electroconvulsive therapy. Ther Adv Chronic Dis. 2012;3:69–85.
Ren J, Li H, Palaniyappan L, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2014;51:181–189.
Dunne RA, McLoughlin DM. Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression. World J Biol Psychiatry. 2012;13:248–258.
Kellner CH, McClintock SM, McCall WV, et al. Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects. J Clin Psychiatry. 2014;75:777.
Kadiyala PK, Kadiyala LD. ECT: a new look at an old friend. Curr Opin Anaesthesiol. 2018;31:453–458.
Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17:244–253.
Sigström R, Kowalec K, Jonsson L, et al. Association between polygenic risk scores and outcome of ECT. Am J Psychiatry. 2022;7:appiajp22010045. doi: 10.1176/appi.ajp.22010045 . [Epub ahead of print].
doi: 10.1176/appi.ajp.22010045
Bahji A, Hawken ER, Sepehry AA, et al. ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatr Scand. 2019;139:214–226.
Kalinowsky LB. Schizophrenia and ECT. Convuls Ther. 1988;4:99.
Sanghani SN, Petrides G, Kellner CH. Electroconvulsive therapy (ECT) in schizophrenia: a review of recent literature. Curr Opin Psychiatry. 2018;31:213–222.
Brunoni AR, Baeken C, Machado-Vieira R, et al. BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis. World J Biol Psychiatry. 2014;15:411–418.
Charlson F, Siskind D, Doi SAR, et al. ECT efficacy and treatment course: a systematic review and meta-analysis of twice vs thrice weekly schedules. J Affect Disord. 2012;138:1–8.
Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology. 2013;38:2467–2474.
Kolar D. Current status of electroconvulsive therapy for mood disorders: a clinical review. Evid Based Ment Health. 2017;20:12–14.
van Schaik AM, Comijs HC, Sonnenberg CM, et al. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatry. 2012;20:5–17.
Petrides G, Tobias KG, Kellner CH, et al. Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature. Neuropsychobiology. 2011;64:129–140.
Milev RV, Giacobbe P, Kennedy SH, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Can J Psychiatry. 2016;61:561–575.
Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20:97–170.